Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes
- PMID: 6345586
- PMCID: PMC370366
- DOI: 10.1172/jci110916
Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes
Abstract
We have developed a new antigenic system for the induction of specific in vitro antibody response in man. The antigen used was purified from the cell wall of Candida albicans strain A and contained greater than 96% polysaccharide mannan. Peripheral blood mononuclear cells from Candida-sensitized donors produced specific antimannan antibodies during a 7-d culture in the presence of mannan absorbed with methylated bovine serum albumin. Two methods were used to detect antimannan antibody responses. Antimannan antibody-producing cells were identified by radioautography with tritiated mannan. Antibody concentration in culture supernatants was measured by an enzyme-linked immunosorbent assay. In both methods, specific IgM and IgG (but not IgA) antibodies were detected. The antibody production to mannan was specific, since an antigenically unrelated polysaccharide (pneumococcal antigen S III) did not bind to methylated bovine serum albumin-mannan-induced blast cells and did not induce antimannan antibody-containing cells. Furthermore, a pulse with an excess of unlabeled mannan abolished [3H]mannan binding, whereas an excess of unlabeled S III did not. Similarly, no antimannan antibody was obtained in influenza virus-stimulated cultures and mannan-stimulated cultures were not inducing antiinfluenza antibodies. The antimannan antibody production was shown to be a T cell-dependent phenomenon. The T helper effect appeared to be radiosensitive. It was under a genetic restriction as it occurred only in autologous or semi-identical but not in allogeneic situations. This system is relatively simple, reproducible, and well suited for the study of specific secondary in vitro antibody responses to polysaccharide antigens in humans.
Similar articles
-
Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.Infect Immun. 1980 Oct;30(1):78-89. doi: 10.1128/iai.30.1.78-89.1980. Infect Immun. 1980. PMID: 7002793 Free PMC article.
-
Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans.Infect Immun. 1997 Sep;65(9):3822-7. doi: 10.1128/iai.65.9.3822-3827.1997. Infect Immun. 1997. PMID: 9284158 Free PMC article.
-
[Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].Mikrobiyol Bul. 2015 Jan;49(1):66-76. doi: 10.5578/mb.8640. Mikrobiyol Bul. 2015. PMID: 25706732 Turkish.
-
Modulation of immune responses by surface polysaccharides of Candida albicans.Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S419-22. doi: 10.1093/cid/10.supplement_2.s419. Rev Infect Dis. 1988. PMID: 2973117 Review.
-
[The significance of Candida serology based on cell wall antigens].Mycoses. 2004;47 Suppl 1:2-10. doi: 10.1111/j.1439-0507.2004.01043.x. Mycoses. 2004. PMID: 15667356 Review. German.
Cited by
-
Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.Infect Immun. 1989 Mar;57(3):693-700. doi: 10.1128/iai.57.3.693-700.1989. Infect Immun. 1989. PMID: 2917780 Free PMC article.
-
Specific binding of antigen onto human T lymphocytes.J Clin Invest. 1986 May;77(5):1557-64. doi: 10.1172/JCI112471. J Clin Invest. 1986. PMID: 3084561 Free PMC article.
-
Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.J Clin Immunol. 1987 Sep;7(5):400-9. doi: 10.1007/BF00917018. J Clin Immunol. 1987. PMID: 2958495
-
Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.Infect Immun. 1990 Aug;58(8):2613-20. doi: 10.1128/iai.58.8.2613-2620.1990. Infect Immun. 1990. PMID: 2142482 Free PMC article.
-
Activation of genetically major histocompatibility complex (MHC) class II-deficient B lymphocytes.J Clin Immunol. 1989 Mar;9(2):125-31. doi: 10.1007/BF00916940. J Clin Immunol. 1989. PMID: 2785529
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous